Clinical Trial: Evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution Under Fasting and Fed Conditions, to Compare Intravenous Arsenic Trioxide, in Acute Promyelocytic Leukemia

U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06882031) titled 'Evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution Under Fasting and Fed Conditions, to Compare Intravenous Arsenic Trioxide, in Acute Promyelocytic Leukemia' on Jan. 23.

Brief Summary: Randomized, Open-Label Study to evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution (SDK001) under Fasting and Fed Conditions, to Compare to IV Arsenic Trioxide

Study Start Date: March 11

Study Type: INTERVENTIONAL

Condition: Acute Promyelocytic Leukemia (APL)

Intervention: DRUG: Treatment A: Arsenic Trioxide (ATO) Intravenous

0.15 mg/kg 2-hour IV infusion of ATO administered under fasted state in single dose

DRUG: T...